Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma

By Karpel Jill P.   Nelson Harold  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2897-2911

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings

By Tohda Yuji   Miyamoto Terumasa  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 203-212

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients

By Zucman David   De Truchis P.   Peytavin Gilles   Descamps Diane   Duvivier C.   Tegna L.   Weiss Laurence   Delassus Jean L.   Benalycherif A.   Landman Roland  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 5, 2013-05 ,pp. : 407-410

Informa Healthcare

Access to resources Recommend Favorite

The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection

By Yamamoto Yoshihiro  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 2, 2012-04 ,pp. : 241-246

Springer Publishing Company

Access to resources Recommend Favorite

Cost‐utility analysis of daily versus intermittent inhaled corticosteroids in mild‐persistent asthma

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 8, 2015-08 ,pp. : 735-746

John Wiley & Sons Inc

Access to resources Recommend Favorite